Methods: The thoracic aorta segments collected from 30 male Wistar rats (20 endothelialized and 20 de-endothelialized vascular rings for each drug in 2 mm wide strips, total number of 120 vascular rings) were suspended into the Krebs solution of the isolated tissue bath system. Phenylephrine was used to induce isometric contraction and tissue samples were treated with verapamil, papaverine and nitroglycerin separately to draw concentration-response curves of isometric vasodilatory responses. This procedure was repeated for de-endothelialized aorta samples.
Results: Papaverine and verapamil induced vasodilatatory responses starting from the concentration of 10-8 M and reached its maximum at concentration of 10-3 M, while nitroglycerin induced vasodilation at lower concentrations starting from a concentration of 10-12 M, reaching its maximum at 10-6 M. Nitroglycerin was the most potent agent, followed by verapamil and papaverine. Efficacy analysis revealed that the most efficient agents were papaverine (140±6.7%), nitroglycerin (110.8±1.35%) and verapamil (99±4.14%), respectively. The results were similar in aorta samples without endothelium (p≥0.05, F test).
Conclusion: In this study examining isolated rat aorta, nitroglycerin was the most potent agent, while papaverine was the most efficient agent. Our study results showed that endothelium played no role in vasodilatation responses of these drugs.
Various vasoactive agents, such as papaverine, verapamil, and nitroglycerin are used to control blood pressure and vascular tone in hemodynamic perturbations.[6-12] Verapamil, a calcium (Ca) channel blocker, papaverine, a phosphodiesterase inhibitor, and nitroglycerin, an activator of guanylate cyclase, are widely used both topically to relieve free arterial graft spasms and systemically to decrease blood pressure and heart rates (with verapamil) in the perioperative period.
In this study, we aimed to study the potency and efficacy of verapamil, papaverine, and nitroglycerin and assess the role of the vascular endothelium in the vasodilatation of isolated rat aortae.
After excision of the aorta from the adhering connective tissue and fat, two pairs of 2 mm wide aortic samples from the proximal ascending aorta were prepared (a total number of four aortic samples from each rat). One pair of rings was kept intact, but the other was de-endothelialized by simply rubbing the endothelial layer with a cotton bud.
The vascular rings were then suspended in a classic tissue bath system on steel hooks attached to an FDT 10-A force displacement transducer (COMMAT Ltd., Ankara, Turkey). As suggested in the literature, the tissue samples were first entrained and adapted to the tissue bath system to reach a level of equilibrium. This procedure was mandatory in order to provide reproducible and correct outcomes. The tissue samples were treated with KCl to depolarize the rings and cause constriction. This was done both to test the viability of the tissue and determine the optimal tension under which the vascular rings could be suspended during the experiments. The KCl was then washed thoroughly, and the rings were suspended under the determined preload for the next 60 minutes to reach equilibrium.
During this period, the Krebs solution in the tissue bath reservoir was continuously oxygenated with 95% O2 and 5% CO2 at 37 °C and changed every 20 minutes to keep the tissues alive.
After 60 minutes, 10-6 M of phenylephrine HCl (Merck, İstanbul, Turkey) was added to the tissue bath system to induce submaximal vasoconstriction of the vascular rings so that any added vasodilatory effect of the drug to be added could be elucidated. The tissues were treated with one of the study drugs only after the aforementioned procedure was completed.
Nitroglycerin (Perlinganit ampule 10 mg / 10 ml, Adeka, İstanbul, Turkey) was added to the tissue bath system cumulatively starting with a concentration of 10-12 M, and this was increased by half logarithmic increments every two minutes until a concentration of 10-6 M was reached. In contrast, verapamil (Isoptin ampule 5 mg / 2 ml, Abbott Laboratories, İstanbul, Turkey) and papaverine (Papaverine HCl amp 0.5 gr, Biofarma Pharmaceutical Industry Co. Inc., İstanbul, Turkey) were added to the system cumulatively starting with a concentration of 10-8 M, and the amounts were increased by half logarithmic increments every two minutes until achieving a concentration of 10-3 M. The dose-response data was obtained via a TDA-97 transducer data acquisition system (COMMAT Ltd., Ankara, Turkey) and recorded using the Polwin 97 software (Commat Ltd., Ankara, Turkey), which was also used to construct the dose-response curves. The responses were calculated as percentages of maximal vasodilatation.
This procedure was repeated for each drug in both the intact and de-endothelialized vascular rings for each aortic specimen. Hence, two intact and two de-endothelialized tissues were studied for each of the aortic specimens obtained from the rats. A total of 120 vascular rings (40 tissue samples for each drug) were studied, half of which had an endothelium (n=20) and half did not (n=20).
Statistical analysis
The responses obtained from the endothelialized
and de-endothelialized aorta segments treated with the three drugs were compared using the Graphpad
Prism version 4.00 for Windows software (Graphpad
Software Inc., La Jolla, CA, USA). The dose-response
curves obtained with each drug were constructed by
non-linear regression, and comparisons between the
curves for the parameters of log(EC50) and maximum relaxion (Emax) were performed by the extra sum of
squares on an F-test. A value of p<0.05 represented the
cut-off point for significance.
Figure 1: Concentration-vasodilatation curve in the endothelialized rat aortae.
Nitroglycerin was the most potent of the three drugs in terms of their log(EC50) values followed by verapamil and papaverine, respectively, and papaverine (140.5±6.7%) had the highest efficacy followed by nitroglycerin (110.8±1.4%) and verapamil (99±4.1%). The results were similar for the aorta samples without the endothelium (p≥0.05; F-test) (Figure 2).
Figure 2: Concentration-vasodilatation curve in nonendothelialized rat aortae.
Figure 3 shows a comparison of the effectiveness of the three drugs with regard to the endothelialized and de-endothelialized rat aortae.
Figure 3: Concentration-vasodilatation curve in endothelialized and non-endothelialized rat aortae.
Zhou et al.[13] reported that nitroglycerin causes vasodilatation between concentrations of 10-8 M and 10-6 M . In our study, we determined that the vasodilatation response of nitroglycerin started at a concentration of 10-12 M, with a maximal response at 10-6 M. Therefore, our data indicates that even at very low doses, nitroglycerin can still cause vasodilatation, which takes place when the cyclic guanosine monophosphate (cGMP) levels increase in the smooth muscle cells.[11,14,15] Rikitake et al.[16] showed that there is no difference in the vasodilatation response between endothelialized and de-endothelialized isolated rabbit aortae when they are induced by nitrogylcerin, and our results using a similar vasodilatation process were in concordance with their study.
Papaverine, a phosphodiesterase III inhibitor, is used widely for relieving graft spasms and is commonly prescribed for patients who undergo coronary artery bypass graft (CABG) surgery to relieve the spasms of the internal mammary artery (IMA).[7,8,10,11] Endothelial injuries caused by the low pH of papaverine are known to have a negative influence on vasodilatation responses. Gao et al.[10] reported that the use of papaverine on IMA grafts increased apoptosis and caused a deterioration in graft functions. In addition, Yoshimura et al.,[17] and Gao et al.[9] found that high concentrations of papaverine (>10-2 M) caused a deterioration in endothelial and smooth muscle functions. In our study, the most pronounced vasodilatation caused by papaverine was at a concentration of 10-2 M . When all of the information regarding papaverine, including our own data, is examined, it can be concluded that papaverine doses that cause maximal vasodilatation also are the ones that are the most harmful. In addition, the fact that the response to papaverine was similar in both the endothelialized and de-endothelialized aorta segments in our study indicates that the endothelium has a minor role in this process.
Verapamil, a voltage-dependent Ca channel blocker, is preferred for the treatment of angina pectoris and hypertension[18-20] and can be used in combination with other vasodilator drugs.[11,12] In our study, the vasodilatation caused by verapamil was less pronounced than that of the other two drugs. Additionally, since the plasma half-life of verapamil is longer than the other drugs, it can be used when a longer duration of vasodilatation is needed, but it should be kept in mind that it will occur at a lower rate.
Declaration of conflicting interests
The authors declared no conflicts of interest with
respect to the authorship and/or publication of this
article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Murat N, Kalkan S, Gidener S. Effect of verapamil on
responses to endothelin-1 in aortic rings from streptozotocininduced
diabetic rats. Pharmacol Res 1999;40:37-40.
2) Lau CW, Chen ZY, Wong CM, Yao X, He Z, Xu H, et al.
Attenuated endothelium-mediated relaxation by acteoside in
rat aorta: Role of endothelial [Ca2+]i and nitric oxide/cyclic
GMP pathway. Life Sci 2004;75:1149-57.
3) Nakae I, Matsumoto T, Omura T, Takashima H, Ohira N,
Tarutani Y, et al. Endothelial modulation and tolerance
development in the vasorelaxant responses to nitrate of rabbit
aorta. Life Sci 2003;73:3083-94.
4) Ortega A, Puerro M, Lopez-Miranda V, Aleixandre A. The
role of endothelium in the calcium-induced reduction of
the contractile response of the rabbit aorta. Gen Pharmacol
1997;28:745-52.
5) Török J, Gerová M. Developmental dynamics of endothelial
and neurogenic control of canine thoracic aorta. Mech
Ageing Dev 1997 ;95:143-52.
6) Dipp MA, Nye PC, Taggart DP. Phenoxybenzamine is
more effective and less harmful than papaverine in the
prevention of radial artery vasospasm. Eur J Cardiothorac
Surg 2001;19:482-6.
7) Takeuchi K, Sakamoto S, Nagayoshi Y, Nishizawa H,
Matsubara J. Reactivity of the human internal thoracic artery
to vasodilators in coronary artery bypass grafting. Eur J
Cardiothorac Surg 2004;26:956-9.
8) Girard DS, Sutton JP 3rd, Williams TH, Crumbley AJ
3rd, Zellner JL, Kratz JM, et al. Papaverine delivery to the
internal mammary artery pedicle effectively treats spasm.
Ann Thorac Surg 2004;78:1295-8.
9) Gao YJ, Stead S, Lee RM. Papaverine induces apoptosis
in vascular endothelial and smooth muscle cells. Life Sci
2002;70:2675-85.
10) Gao YJ, Yang H, Teoh K, Lee RM. Detrimental effects of
papaverine on the human internal thoracic artery. J Thorac
Cardiovasc Surg 2003;126:179-85.
11) Formica F, Ferro O, Brustia M, Corti F, Colagrande L,
Bosisio E, et al. Effects of papaverine and glycerylnitrateverapamil
solution as topical and intraluminal vasodilators for internal thoracic artery. Ann Thorac Surg 2006;81:120-4.
12) Mussa S, Guzik TJ, Black E, Dipp MA, Channon KM,
Taggart DP. Comparative efficacies and durations of action
of phenoxybenzamine, verapamil/nitroglycerin solution,
and papaverine as topical antispasmodics for radial artery
coronary bypass grafting. J Thorac Cardiovasc Surg
2003;126:1798-805.
13) Zhou ZH, Jiang JL, Peng J, Deng HW, Li YJ. Reversal of
tolerance to nitroglycerin with N-acetylcysteine or captopril:
a role of calcitonin gene-related peptide. Eur J Pharmacol
2002;439:129-34.
14) Pi X, Yan C, Kim D, Chen J, Berk BC. Differential
expression of genes from nitrate-tolerant rat aorta. J Vasc Res
2002;39:304-10.
15) Fukami Y, Toki Y, Numaguchi Y, Nakashima Y, Mukawa
H, Matsui H, et al. Nitroglycerin-induced aortic relaxation
mediated by calcium-activated potassium channel
is markedly diminished in hypertensive rats. Life Sci 1998;63:1047-55.
16) Rikitake Y, Hirata K, Kawashima S, Inoue N, Akita H,
Kawai Y, et al. Inhibition of endothelium-dependent arterial
relaxation by oxidized phosphatidylcholine. Atherosclerosis
2000;152:79-87.
17) Yoshimura S, Hashimoto N, Goto Y, Sampei K, Tsukahara
T, Iihara K. Intraarterial infusion of high-concentration
papaverine damages cerebral arteries in rats. AJNR Am J
Neuroradiol 1996;17:1891-4.
18) Triggle DJ. The pharmacology of ion channels: with
particular reference to voltage-gated Ca2+ channels. Eur J
Pharmacol 1999;375:311-25.